Myra Cocker
Global Director of Clinical Science, Cardiovascular, Siemens Healthineers
Myra Cocker PhD
Global Director of Clinical Science, Cardiovascular, Siemens Healthineers
Stan Tsvirko
Executive Director, Medical Intelligence and Technology, Novartis
Stan Tsvirko
Executive Director, Medical Intelligence and Technology, Novartis
Elaine Brennan
Executive Director, Global Strategic Partnerships, Northwell Health
Elaine Brennan
Executive Director, Global Strategic Partnerships, Northwell Health
Adam Shain
VP of Patient Solutions, Aptar Digital Health
Adam Shain
VP of Patient Solutions, Aptar Digital Health
Product: Migraine Buddy's Weather and Trigger Advanced Reports
Company: Aptar Digital Health
About the Product:
Migraine Buddy is a mobile application developed by Aptar Digital Health, a global leader in digital health, and part of AptarGroup, Inc. Migraine Buddy was first launched in 2014 and aims to empower patients suffering from headaches and migraine through data-driven insights. Migraine Buddy quickly gained traction among migraine sufferers due to its user-friendly design and comprehensive tracking capabilities, allowing them to track their symptoms and triggers easily. The app's success attracted significant attention, leading to partnerships with headache and research institutions. Over the past 10 years, Migraine Buddy has become the number one mobile application for tracking headaches and migraines. Recommended by the world's leading neurologists, it enables migraine sufferers to learn and better communicate about their headaches. Our community of 3.7 million users across 132 countries contributes to migraine awareness and research. Migraine affects 1 in 7 people worldwide, with only 60% having access to treatment.
Elizabeth Schwarzbach
Chief Business Officer, BigHat Biosciences
Elizabeth Schwarzbach
Chief Business Officer, BigHat Biosciences
Product: Milliner™
Company: BigHat Biosciences
About the Product:
BigHat Biosciences is a preclinical-stage drug discovery company that uses machine learning and synthetic biology to design safer, more effective antibodies for patients. We are a Series B-stage biotech outside San Francisco with a team-oriented, inclusive, and family-friendly culture. We have a pipeline of wholly-owned and partnered programs in therapeutic areas with high unmet need, such as cancer and inflammation. BigHat has raised >$100M from top investors, including Section 32, a16z, and 8VC.
Jennifer Guild
Senior Program Director, Clinical ink
Jennifer Guild
Senior Program Director, Clinical ink
Product: GlucoseReady™
Company: Clinical ink
About the Product:
GlucoseReady is a novel, fully integrated GCP eClinical platform designed to optimize patient engagement and retention for cardiometabolic areas including diabetes and chronic weight management. It includes a full suite of eCOA capabilities that can address capture of both active patient diaries and passive wearables and complex sensor data. This includes a range of connected CGM and BGM devices. The implementation of AI algorithms are designed to improve patient outcomes and enhance safety surveillance. We believe this unique tool represents the new gold standard for retention and data capture in the new era of GLP-1 cardiometabolic clinical trials.
Dennis P. Wall
Founder & Chief officer of Science and Innovation, Cognoa
Dennis P. Wall, PhD
Founder & Chief officer of Science and Innovation, Cognoa
Product: Canvas Dx ASD Diagnostic Aid
Company: Cognoa
About the Product:
Cognoa's breakthrough product, Canvas Dx, is the first and only FDA-authorized autism diagnostic that uses responsible AI to empower doctors to quickly, accurately, and fairly diagnose developmental risk without bias in children 1.5 through 6 years of age.
Canvas Dx creates “instant specialists” by equipping providers with a definitive solution to confidently act on early developmental concerns and make accurate diagnoses in days, not months or years. With Canvas Dx, more families - particularly those in historically under-served populations - will be able to begin critical interventions earlier, rather than wait to see a pediatric specialist and delay progress.
David Crowley
Program Manager Pharma Partnerships, Empatica
David Crowley
Program Manager Pharma Partnerships, Empatica
Product: Empatica Health Monitoring Platform
Company: Empatica
About the Product:
Empatica is a full-stack digital healthcare company and a pioneer in digital biomarker development and continuous health monitoring driven by AI. The FDA-cleared Empatica Health Monitoring Platform consists of the medical-grade EmbracePlus wearable, software, and digital measures, that can accurately and continuously monitor patient health remotely and unobtrusively, across a range of health conditions. Empatica’s solutions are currently being used by thousands of research partners, institutions, and patients, to run decentralized clinical trials, develop novel digital biomarkers, conduct academic research with real-world data, and monitor neurological conditions.
Avie Luthra
Psychiatrist Consultant, MyPsychAdmin
Avie Luthra
Psychiatrist Consultant, MyPsychAdmin
Product: MPA
Company: MyPsychAdmin
About the Product:
MRIs scan the brain; Dopplers detect clots; colonoscopies hunt the bowel wall. What is the equivalent in Mental Health?
MyPsychAdmin - an app which investigates the ‘body’ of notes, turning 1000s of pages into digestible images and summaries. Using natural language processing, it produces results at approx. 1000 pages/min saving hours of reading. It then feeds this information into letter/report templates, saving hours of writing.
MyPsychAdmin liberates the Mental Health Clinician from Admin by furnishing them with the patient's story accurately and quickly, and by releasing the time and tools needed to empower their patient’s recovery.
Yogendra Bobra
CEO, Omnyk Inc.
Yogendra Bobra
CEO, Omnyk Inc.
Product: OmnyKare
Company: Omnyk
About the Product:
OmnyKare is an end-to-end remote patient care solution, specifically targeted for patients with cardiovascular diseases (CVD) and patients with multiple chronic diseases.
OmnyKare has 3 key elements; A finger wearable device for collection of body vitals, A mobile application for delivery of alerts, reports, etc.
Unique capabilities of our solution are; ability to collection body vitals without missing a "heart beat", ability for real-time analytics, delivery of real-time alerts, based on advanced AI/ML based algorithms and customer specific criteria's. This enables healthcare professional, in partnership with Omnyk, to deliver timely "Data driven personalized care" when warrened for.
Chrissa McFarlane
Chief Executive Officer, Patientory, Inc.
Chrissa McFarlane
Chief Executive Officer,
Patientory, Inc.
Product: Patientory
Company: Patientory, Inc.
About the Product:
A population health data management and analytics company, Patientory, Inc. is the largest health data marketplace that empowers users to take charge of their health. As a blockchain and HIPAA software application that includes an Enterprise web portal Neith and consumer mobile App, the purpose of Patientory is to securely facilitate and encrypt the transmission of health data while empowering healthcare professionals and patients in storing healthcare data and the ability to monetize that secure data. Through its two decentralized applications, Patientory Inc. provides patients with ownership and insights and enterprises with comprehensive healthcare data intelligence.
Rajarshi Banerjee
CEO, Perspectum
Rajarshi Banerjee
CEO, Perspectum
Product: CoverScan
Company: Perspectum
About the Product:
CoverScan is an MRI software for quantifying the characteristics of 6 different organs using a single noninvasive scan, enabling clinicians to visualize and assess multi-organ health. Referring clinicians are provided with a report of 49 metrics for easy assessment of multi-organ function. The information provided by CoverScan, in conjunction with other tests and clinical evaluation of the patient, may form part of a clinical decision-making pathway and enable physicians to make more informed clinical decisions for patients. Importantly, repeated analyses using CoverScan may aid clinicians to monitor patients and personalize treatments. CoverScan is an advanced cloud-based software suite, delivered as a software as a service solution, and uses existing clinical MR infrastructure.
David Stoffel
Chief Business Officer, RapidAI
David Stoffel
Chief Business Officer, RapidAI
Product: iSchemaView Rapid
Company: RapidAI
About the Product:
RapidAI provides cutting-edge medical imaging software that leverages deep clinical AI to enhance decision-making, streamline care team workflows, and ensure that every patient, whether facing stroke, aneurysm, pulmonary embolism, or aortic disease, benefits from advanced technology and clinical expertise.
Pau Herrero
Lead Research Engineer, Roche Diagnostics
Pau Herrero, PhD
Lead Research Engineer, Roche Diagnostics
Product: Accu-Chek SmartGuide Predict app
Company: Roche Diagnostics
About the Product:
The Accu-Chek® SmartGuide Predict app initiates a paradigm shift in diabetes management moving from reactive treatment towards preventive care using AI and personalized context data. The app provides users with multi-horizon glucose predictions, enabling them to intuitively understand their past, current, and forecasted glycemic status and to take informed actions at the right time. This holds the promise of a reduction in diabetes complications as well as lightening the mental burden for people with diabetes.
Zahid Ali Ashraf
Founder & CEO, Techmedo
Zahid Ali Ashraf
Founder & CEO, Techmedo
Product: AI based Primary Healthcare Operating System
Company: Techmedo
About the Product:
Picture a world where healthcare transcends borders and barriers, where care is delivered from the cloud on the ground. This is no distant dream; it's the reality being shaped by TECHMEDO's Healthcare Operating System to deliver Quality primary healthcare for population health. In our hands, we hold the future of healthcare. AI, and data analytics power our system, forging a bridge between tech and care. This Operating System doesn't just amplify healthcare providers; it shakes the very core of traditional care, revolutionizing processes for efficiency and personalization.
Jamie Stern
Sr. Director of Clinical Strategy and Care Pathway Programs, Viz.ai
Jamie Stern
Sr. Director of Clinical Strategy and Care Pathway Programs, Viz.ai
Product: ContaCT
Company: Viz.ai
About the Product:
Viz HCM, a hypertrophic cardiomyopathy (HCM) artificial intelligence (AI) detection algorithm, automatically reviews routine electrocardiograms (ECGs) from across a health system to identify suspected HCM cases and notifies the appropriate cardiologists and care team on the Viz mobile application. Clinicians can then easily review the patient’s ECG, coordinate follow-up with an echocardiogram for diagnosis, and use the Viz Echo Viewer to review images and access echocardiogram reports. With the use of Viz HCM, which is integrated into the Viz.ai Platform, more patients with suspected HCM can be identified earlier using AI and triaged for diagnosis and further evaluation.
Antoine Robilliard
VP Health Solutions, Withings
Antoine Robilliard
VP Health Solutions, Withings
Product: Body Scan
Company: Withings
About the Product: